Nicorette Inhalator (Nicotine)

The nicotine released from the inhalator binds to nicotinic acetylcholine receptors, especially the α4β2 subtype, in the brain. This activation produces modest dopamine release, mimicking the rewarding effect of smoking and thereby easing cravings and withdrawal while allowing the user to taper nicotine exposure over time.

The specific dosing regimen for Nicorette Inhalator is determined by a healthcare professional based on the individual’s smoking history, level of dependence, and overall health. The prescriber will advise the number of inhalations per day and the duration of therapy, which may be adjusted as the quit‑plan progresses.

Safety data for nicotine inhalation during pregnancy or lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss the risks and benefits with their healthcare provider before using Nicorette Inhalator, as nicotine exposure may affect fetal development or infant health.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any temperature‑controlled requirements) and the necessary import documentation.

Compared with nicotine patches or gum, the inhalator provides a faster onset of nicotine absorption through the oral mucosa, more closely resembling the hand‑to‑mouth ritual of smoking. This can improve satisfaction for some users, while still delivering lower nicotine levels than cigarettes. Choice of product depends on personal preference, lifestyle and clinical considerations.

Store the inhalator at ambient temperature, preferably below 25 °C, in its original packaging. Keep it away from moisture, direct sunlight and heat sources. Ensure the device is kept out of reach of children and pets. Do not expose the inhalator to extreme temperatures or humidity, as this may affect nicotine stability.

The device is an oromucosal inhalation system. To use, place the mouthpiece in the mouth, inhale gently, and press the activation button to release a measured dose of nicotine. The user should follow the prescriber’s instructions regarding the number of inhalations per day and avoid deep or rapid inhalations that may cause irritation.

Serious risks include allergic reactions such as rash, swelling, or difficulty breathing, and cardiovascular events like chest pain or irregular heartbeat, especially in individuals with pre‑existing heart disease. Persistent severe nausea or vomiting and bronchospasm are also rare but require immediate medical attention.

Individuals with known hypersensitivity to nicotine or any component of the inhalator should avoid its use. Those who have recently experienced a myocardial infarction, uncontrolled hypertension, or severe cardiovascular disease should consult a physician before starting therapy. Children, adolescents, and pregnant or breastfeeding women should only use the product under medical supervision.